日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Implementing generative artificial intelligence in precision oncology: safety, governance, and significance

在精准肿瘤学中应用生成式人工智能：安全性、治理和意义

期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-026-01781-y
Hamamoto, Ryuji; Koyama, Takafumi; Takahashi, Satoshi; Yasuda, Tomohiro; Kobayashi, Kazuma; Akagi, Yu; Kouno, Nobuji; Sudo, Kazuki; Hirata, Makoto; Sunami, Kuniko; Kubo, Takashi; Katayama, Hiroshi; Takashima, Atsuo; Taniguchi, Tomonori; Matsumoto, Hiromi; Shibaki, Ryota; Asada, Ken; Komatsu, Masaaki; Kaneko, Syuzo; Yamada, Masayoshi; Horinouchi, Hidehito; Tanaka, Katsuya; Goto, Yasushi; Kato, Ken; Saito, Yutaka; Nakamura, Kenichi; Yamamoto, Noboru
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Nivolumab with definitive chemoradiotherapy for oesophageal squamous cell carcinoma (NOBEL): a multicentre, single-arm, phase 2 feasibility trial

纳武利尤单抗联合根治性放化疗治疗食管鳞状细胞癌（NOBEL）：一项多中心、单臂、II期可行性试验

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103689
Nomura, Motoo; Sakanaka, Katsuyuki; Shimizu, Juko; Ohashi, Shinya; Katada, Chikatoshi; Watanabe, Akinori; Amanuma, Yusuke; Minashi, Keiko; Kato, Ken; Kojima, Takashi; Nagashima, Kengo; Kim, Ihhwa; Tada, Harue; Nakakura, Akiyoshi; Muto, Manabu
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Survival after pathological complete response following neoadjuvant chemotherapy versus chemoradiotherapy for oesophageal squamous cell carcinoma

食管鳞状细胞癌新辅助化疗与放化疗后病理完全缓解后的生存率比较

期刊:British Journal of Surgery
影响因子:8.8
doi:10.1093/bjs/znag012
Okui, Jun; Matsuda, Satoru; Nagashima, Kengo; Sato, Yasunori; Kawakubo, Hirofumi; Ruhstaller, Thomas; Thuss-Patience, Peter; Nilsson, Magnus; Klevebro, Fredrik; Tan, Lijie; Zhang, Shaoyuan; Aparicio, Thomas; Piessen, Guillaume; van der Zijden, Charlène; Mostert, Bianca; Wijnhoven, Bas P L; Tsushima, Takahiro; Takeuchi, Hiroya; Kato, Ken; Kitagawa, Yuko
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Conditional recurrence-free survival after curative esophagectomy: individual patient data analysis of 11 trials

根治性食管切除术后条件性无复发生存率：11项试验的个体患者数据分析

期刊:Jnci-Journal of the National Cancer Institute
影响因子:7.2
doi:10.1093/jnci/djaf347
Okui, Jun; Matsuda, Satoru; Nagashima, Kengo; Sato, Yasunori; Kawakubo, Hirofumi; Ruhstaller, Thomas; Thuss-Patience, Peter; Nilsson, Magnus; Klevebro, Fredrik; Tan, Lijie; Zhang, Shaoyuan; Aparicio, Thomas; Piessen, Guillaume; van der Zijden, Charlène; Mostert, Bianca; Wijnhoven, Bas P L; Tsushima, Takahiro; Takeuchi, Hiroya; Kato, Ken; Kitagawa, Yuko
发表日期：2026
文献求助 收藏

Comprehensive Genomic Profiling of Advanced Anal Adenocarcinoma in Japan

日本晚期肛门腺癌的综合基因组分析

期刊:Jco Precision Oncology
影响因子:5.6
doi:10.1200/PO-25-00562
Ogura, Nozomu; Hirano, Hidekazu; Shiraishi, Kouya; Fujii, Hiroyuki; Hirose, Toshiharu; Shoji, Hirokazu; Okita, Natsuko; Takashima, Atsuo; Koyama, Takafumi; Yonemori, Kan; Kato, Ken
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Tislelizumab + Chemotherapy in Gastric Cancer: Long-Term RATIONALE-305 Randomized Trial Follow-up

替雷利珠单抗联合化疗治疗胃癌：RATIONALE-305随机试验的长期随访

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03415-0
Cruz-Correa, Marcia; Oh, Do-Youn; Kato, Ken; Tabernero, Josep; Bai, Yuxian; Shi, Jianhua; Lee, Keun-Wook; Hirano, Hidekazu; Spigel, David; Wyrwicz, Lucjan; Pazo Cid, Roberto; Cubillo Gracián, Antonio; Xu, Yaling; Sheng, Tao; Yang, Silu; Xu, Rui-Hua; Moehler, Markus
胃癌
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

The safety and short-term efficacy of nivolumab plus ipilimumab for advanced esophageal squamous cell carcinoma

纳武利尤单抗联合伊匹木单抗治疗晚期食管鳞状细胞癌的安全性和短期疗效

期刊:Esophagus
影响因子:3.8
doi:10.1007/s10388-025-01162-3
Shiraishi, Kazuhiro; Yamamoto, Shun; Yoshinami, Yuri; Ogura, Nozomu; Itoyama, Mai; Imazeki, Hiroshi; Yokoyama, Kazuki; Honma, Yoshitaka; Kashihara, Tairo; Kurita, Daisuke; Ishiyama, Koshiro; Oguma, Junya; Igaki, Hiroshi; Daiko, Hiroyuki; Seto, Yasuyuki; Kato, Ken
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Real-world comparison between neoadjuvant FLOT therapy and DCF therapy for resectable esophagogastric junction adenocarcinoma

新辅助FLOT方案与DCF方案治疗可切除食管胃交界处腺癌的真实世界比较

期刊:Esophagus
影响因子:3.8
doi:10.1007/s10388-025-01168-x
Shiraishi, Kazuhiro; Yamamoto, Shun; Hirose, Toshiharu; Imazeki, Hiroshi; Yokoyama, Kazuki; Honma, Yoshitaka; Hashimoto, Taiki; Kashihara, Tairo; Kurita, Daisuke; Ishiyama, Koshiro; Oguma, Junya; Igaki, Hiroshi; Daiko, Hiroyuki; Seto, Yasuyuki; Kato, Ken
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Safety and short-term efficacy of neoadjuvant FLOT therapy in cisplatin-unfit patients with resectable esophageal squamous cell carcinoma

新辅助FLOT方案治疗不适合顺铂治疗的可切除食管鳞状细胞癌患者的安全性和短期疗效

期刊:Esophagus
影响因子:3.8
doi:10.1007/s10388-025-01160-5
Yoshinami, Yuri; Yamamoto, Shun; Shiraishi, Kazuhiro; Imazeki, Hiroshi; Yokoyama, Kazuki; Honma, Yoshitaka; Kurita, Daisuke; Ishiyama, Koshiro; Oguma, Junya; Hashimoto, Taiki; Kashihara, Tairo; Daiko, Hiroyuki; Kato, Ken
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Early Mycophenolate Mofetil Combination Therapy as an Effective Approach for Immune-Related Hepatitis Induced by Immune Checkpoint Inhibitors in Patients With Solid Tumor

早期吗替麦考酚酯联合治疗是治疗实体瘤患者免疫检查点抑制剂诱发的免疫相关性肝炎的有效方法

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.71720
Igawa, Yukiko Shimoda; Yoshida, Tatsuya; Sato, Jun; Yoshinami, Yuri; Hibino, Yukiko; Arima, Takamichi; Maruki, Yuta; Shoji, Hirokazu; Namikawa, Kenjiro; Sudo, Kazuki; Honma, Yoshitaka; Okita, Natsuko; Hashimoto, Hironobu; Yamazaki, Naoya; Okusaka, Takuji; Yonemori, Kan; Yamamoto, Noboru; Ohe, Yuichiro; Kato, Ken
Checkpoint
肝炎
免疫/内分泌
发表日期：2026
文献求助 收藏